Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRAGet Free Report) have been given a consensus recommendation of “Moderate Buy” by the eleven brokerages that are currently covering the firm, MarketBeat reports. Five research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $15.35.

SBRA has been the topic of several research analyst reports. Mizuho boosted their price target on shares of Sabra Health Care REIT from $15.00 to $17.00 and gave the stock a “buy” rating in a research note on Wednesday, January 3rd. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Sabra Health Care REIT in a research note on Tuesday, January 30th. They issued a “buy” rating and a $21.00 price target on the stock. Finally, Wedbush restated an “outperform” rating and issued a $17.00 target price on shares of Sabra Health Care REIT in a report on Thursday, February 29th.

Get Our Latest Research Report on SBRA

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in SBRA. CWM LLC raised its holdings in shares of Sabra Health Care REIT by 363.5% during the third quarter. CWM LLC now owns 1,780 shares of the real estate investment trust’s stock worth $25,000 after purchasing an additional 1,396 shares during the last quarter. Tennessee Valley Asset Management Partners purchased a new position in shares of Sabra Health Care REIT during the fourth quarter worth $25,000. Chilton Capital Management LLC purchased a new position in shares of Sabra Health Care REIT during the first quarter worth $26,000. RVW Wealth LLC purchased a new position in Sabra Health Care REIT in the third quarter valued at $30,000. Finally, Point72 Hong Kong Ltd purchased a new position in Sabra Health Care REIT in the second quarter valued at $31,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Health Care REIT Stock Up 1.6 %

SBRA opened at $14.48 on Monday. The stock has a market cap of $3.35 billion, a price-to-earnings ratio of 289.60, a price-to-earnings-growth ratio of 5.22 and a beta of 1.16. Sabra Health Care REIT has a fifty-two week low of $10.30 and a fifty-two week high of $14.91. The company has a debt-to-equity ratio of 0.86, a quick ratio of 3.41 and a current ratio of 3.41. The firm’s fifty day moving average is $13.96 and its 200 day moving average is $14.05.

Sabra Health Care REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, February 29th. Shareholders of record on Tuesday, February 13th were issued a $0.30 dividend. The ex-dividend date of this dividend was Monday, February 12th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 8.29%. Sabra Health Care REIT’s dividend payout ratio is currently 2,400.00%.

About Sabra Health Care REIT

(Get Free Report

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.

Featured Articles

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.